Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery
Emulate official blog RSS · Indexed industry source record · Source published: Wed Aug 27 2025 20:53:46 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 07:04:42 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models has never been greater. That’s why Emulate recently launched the AVA Emulation System , the first self-contained Organ-on-a-Chip workstation designed to bring scale, reproducibility, and accessibility to this
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.